Literature DB >> 7627947

Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells.

R Corvi1, L Savelyeva, M Schwab.   

Abstract

Amplification of the human N-MYC proto-oncogene is frequently seen either in extrachromosomal double minutes or in homogeneously staining regions of aggressively growing neuroblastomas. N-MYC maps to chromosome 2 band p23-24, but homogeneously staining regions have never been observed at this band, suggesting transposition of N-MYC during amplification. Previous studies had suggested that in cells with amplified N-MYC the chromosomes 2 appear to be unaltered and to carry one apparently normal copy of N-MYC each. In contrast, the contribution of N-MYC to tumors which lack amplification has been unclear. We here show, by fluorescence in situ hybridization, that N-MYC is occasionally duplicated at its resident site in neuroblastoma cell lines previously thought to have a single copy gene. Additionally, we detected duplication in a neuroblastoma cell line carrying amplification. Our results raise the possibility that duplication may, in some neuroblastomas, either be a prelude to amplification or an alternative pathway by which N-MYC becomes activated.

Entities:  

Mesh:

Year:  1995        PMID: 7627947

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma.

Authors:  Ryota Souzaki; Tatsuro Tajiri; Risa Teshiba; Mayumi Higashi; Yoshiaki Kinoshita; Sakura Tanaka; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2011-03       Impact factor: 1.827

Review 2.  Patterns of oncogene activation in human neuroblastoma cells.

Authors:  R Corvi; L Savelyeva; M Schwab
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

3.  Germline duplication of chromosome 2p and neuroblastoma.

Authors:  J S Patel; J Pearson; L Willatt; T Andrews; R Beach; A Green
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

4.  2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.

Authors:  Marta Jeison; Shifra Ash; Gili Halevy-Berko; Jacques Mardoukh; Drorit Luria; Smadar Avigad; Galina Feinberg-Gorenshtein; Yacov Goshen; Gabriel Hertzel; Joseph Kapelushnik; Ayelet Ben Barak; Dina Attias; Ran Steinberg; Jerry Stein; Batia Stark; Isaac Yaniv
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 5.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

Review 6.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

7.  MYCN Amplification in Neuroblastoma: a Paradigm for the Clinical Use of an Oncogene.

Authors:  Manfred Schwab
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

8.  FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.

Authors:  Nie Dongsong; Jian Y Zhou
Journal:  Mol Biol Rep       Date:  2009-12-05       Impact factor: 2.316

9.  Fast detection of MYCN copy number alterations in brain neuronal tumors by real-time PCR.

Authors:  S G Malakho; A Korshunov; A M Stroganova; A B Poltaraus
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

10.  Regulation of MYCN expression in human neuroblastoma cells.

Authors:  Joannes F M Jacobs; Hans van Bokhoven; Frank N van Leeuwen; Christina A Hulsbergen-van de Kaa; I Jolanda M de Vries; Gosse J Adema; Peter M Hoogerbrugge; Arjan P M de Brouwer
Journal:  BMC Cancer       Date:  2009-07-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.